In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Related
Latest
FMI names finalists for 2026 Store Manager Awards
The awards recognize grocery retail leaders who have demonstrated excellence in operations, leadership, innovation and community engagement.
Robotics power CVS supply chain modernization
CVS Pharmacy uses robotics and automation at its Hainesport, N.J., center to improve inventory, speed store replenishment, and boost supply chain efficiency.
FemiClear acquired by Venture Life Group to expand women’s health platform
Venture Life Group acquired FemiClear and CUROXEN, boosting its self-care portfolio and U.S. women's health market presence.
NACDS president and CEO Steven Anderson receives the association profession's highest honor – The ASAE Key Award
Prestigious recognition salutes career of transformational leadership.